Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
Dear all I was invested here in the past. I am not holding anymore here. I did make some money with VRP trading while back. Case for 554 is really strong. I’m not commenting on SP. the only reason I thought of writing here is I invested my daughters isa in Arix investment trust and they have Verona in their portfolio. Usually these companies do their homework better than PIs. I’m waiting on another share to give me returns. I will reinvest but this time to hold it for long. I’m out of trading. Best wishes to all
They have very busy and tight time schedule. If you look in previous rns you will see they have followed all timescales regarding 554 studies so far. Free k my memory they are conducting trials this year as wlll and 2018 was for phase 3.
Holdings rns.
That's a great find and nice 1st post.
Was ITV not said 6 months from 25th July or something like that?
Hi Rhodi, I have an average of 6.2 as well. I am in ctag too. Started collecting from 2.4 and it went upto 23. So not concerned here at all. We will be in double digits too. May be next year. But such a solid product and strong IIs like polar capital makes me extremely confident.
I don't think there is anything to worry is about asthma tablet. 554 is for COPD and asthma. Not necessarily of a drug is effective for one means it will work for other condition. GLA
Hi Chester no detailed reports available yet. We only got bits ad on pieces of study results. GLA
Hi apps just wondering what news we expecting? Thanks
The gentlemen (and ladies) of Verona Pharma are reportedly considering a listing on NASDAQ, the US electronic stock exchange. After raising £44.7million through an oversubscribed placing to fund the development of its lung disease treatment, it announced that it was pursuing ‘commercially reasonable efforts’ to obtain a listing on NASDAQ and raise a further tranche of funding in the future. Non-executive chairman David Ebsworth said that a NASDAQ listing was a ‘natural evolution’ in the group’s corporate strategy to focus on the US market.
Hi Wudi arix bioscience is one of the II here. It's led by Woodford. So yes technically he is here. I know he had a bit of a bad luck with pharma in last 2 years. Hopefully VRP will be his lucky charm.
I see you in Mtfb too. that's excellent. Cornerstone investments, where one or more investors agree in advance to subscribe for a certain number of shares in a forthcoming initial public offering (IPO), are a relatively new feature of the European IPO markets.
Once again good find. I'm going to disect this RNS over the weekend. Loads of info in it. Thanks to all who posting it for benefit of us. GLA
Hi Thelix, just wondering this placing of 45 million will have an impact on sp? I think lot people got caught out when moved up after placing RNS. Some are waiting for Brexit got to clear.
Good find sellonnews. So Neil Woodford is an investor through Arix bioscience. No wonder we are up.
We have added 7milions in market cap. Make of it whatever you want. GLA
That's why I'm invested here. Efficacy of PDE inhibitors has never been in doubt. However, over the years’ putative drugs have failed due to side effects. VRP has overcome this with a new formulation delivered via a nebuliser. With the first tranche of funding secured and a second tranche to be delivered when the company undertakes a listing on NASDAQ, VRP is well positioned for the future.
Oh ok I get you now. Of course we can buy on stock exchange. Thanks. next 6-12 months are going to be very exciting.
Where you getting this sp of 14-23p pre-IPO? Also what impact will have of us market opening later on? Also read in RNS that placing shares will be sold in us market? As far as I know we are in uk and Germany. Can someone please explain? GLA